ArticleBiometrical journal. Biometrische Zeitschrift2026
Bayesian Integrative Detection of Structural Variations With False Discovery Rate Control.
Article in Biometrical journal. Biometrische Zeitschrift, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bayesian Integrative Detection of Structural Variations With False Discovery Rate Control.Biometrical journal. Biometrische Zeitschrift · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Recent advances in long-read sequencing technologies have empowered the detection of structural variations (SVs) associated with genetic diseases. Despite the availability of numerous SV callers and efforts to merge SVs from multiple tools, there remains limited research on quantifying the confidence levels for the reported results. In this work, we propose a Bayesian integration model that combines SV calls from different tools. Notably, we introduce an approach for false discovery rate (FDR) control and provide a quantitative measure for the merged SVs. Our model can handle cases where certain tools lack quality scores, showcasing its flexibility in incorporating additional tools. Through extensive simulation studies, we evaluate the performance of our method under various conditions, demonstrating the FDR estimation accuracy and improved F1 score. Furthermore, we validate our model using simulated human genome sequencing data and the HG002 dataset.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.